The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts
Abstract
Decellularized equine carotid arteries (dEAC) may represent a reasonable alternative to alloplastic materials in vascular replacement therapy. Acellularity of the matrix is standardly evaluated by DNA quantification what however may not record sufficiently the degree of matrix immunogenicity. Thus, our aim was to analyze dEAC with a low DNA content for residual cellular proteins. A detergent-based decellularization protocol including endonuclease treatment resulted in dEAC with 0.6 ± 0.15 ng DNA/mg dry weight representing 0.33 ± 0.14% of native tissue DNA content. In contrast, when matrices were homogenized and extracted by high detergent concentrations westernblot analyses revealed cytosolic and cytosceleton proteins like GAPDH and smooth muscle actin which were depleted to 4.1 ± 1.9% and 13.8 ± 0.55%, resp. Also putative immunogenic MHC I complexes and the alpha-Gal epitop were reduced to only 14.8 ± 1.2% and 15.1 ± 2.05%. Mass spectrometry of matrix extracts identified 306 proteins belonging to cytosol, organelles, nucleus and cell membrane. Moreover, aqueous matrix extracts evoked a pronounced antibody formation when administered in mice and thus display high immunogenic potential. Our data indicate that an established decellularization protocol which results in acellular matrices evaluated by low DNA content reduces but not eliminates cellular components which may contribute to its immunogenic potential in vivo.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Endonuclease treatment can eliminate DNA while other cellular components still exist in the scaffold.
“Besides, Böer et al. showed that endonuclease treatment, as a popular agent applied in many decellularization protocols, could misunderstand us and cause DNA elimination while other cellular components still exist in the scaffold.”
From Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine (2023) · cites this paper as [54]
Böer et al.'s decellularization protocol virtually eliminated DNA and significantly reduced cellular proteins but quantified over 300 cellular proteins, including cytosol, cell membrane, organelles, nucleus, and cytoskeleton.
“Although their decellularization protocol virtually eliminated DNA and significantly reduced cellular proteins, they quantified over 300 cellular proteins, including ingredients of cytosol, cell membrane, organelles, nucleus, and cytoskeleton.”
From Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine (2023) · cites this paper as [54]
Quantification of residual DNA as a potent immunogen and indirect index of remaining cell materials is a practical tool to estimate remaining immunogen amount throughout dECM.
“The quantification of residual DNA as a potent immunogen and indirect index of remaining cell materials is a practical tool to estimate the remaining immunogen amount throughout the dECM [54–56].”
From Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine (2023) · cites this paper as [54]
Remaining cellular proteins after Böer et al.'s protocol provoked a high immunogenic response in their in vivo study.
“These remaining proteins provoked a high immunogenic response in their in vivo study [54].”
From Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine (2023) · cites this paper as [54]
Cites
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · see citing works
Decellularization of tissues and organs
Gilbert, T. W., Sellaro, T. L., & Badylak, S. F. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.02.014 · Cited by 2,222 · see citing works
Brown, B. N., Valentin, J. E., Stewart-Akers, A. M., McCabe, G. P., & Badylak, S. F. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.040 · Cited by 896 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications
Gilpin, A., & Yang, Y. (2017) · BioMed Research International · doi:10.1155/2017/9831534 · Cited by 742 · see citing works
Extracellular matrix-based biomaterial scaffolds and the host response
Aamodt, J. M., & Grainger, D. W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.003 · Cited by 509 · see citing works
Kasravi, M., Ahmadi, A., Babajani, A., Mazloomnejad, R., Hatamnejad, M. R., Shariatzadeh, S., Bahrami, S., & Niknejad, H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00348-z · Cited by 316 · see citing works
Immunogenicity in xenogeneic scaffold generation: Antigen removal vs. decellularization
Wong, M. L., & Griffiths, L. G. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.01.028 · Cited by 254 · see citing works
Regulation of decellularized matrix mediated immune response
Chakraborty, J., Roy, S., & Ghosh, S. (2020) · Biomaterials Science · doi:10.1039/c9bm01780a · Cited by 130 · see citing works
Massaro, M. S., Pálek, R., Rosendorf, J., Červenková, L., Liška, V., & Moulisová, V. (2021) · Materials Science and Engineering: C · doi:10.1016/j.msec.2021.112203 · Cited by 82 · see citing works
Haykal, S., Zhou, Y., Marcus, P., Salna, M., Machuca, T., Hofer, S. O. P., & Waddell, T. K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.044 · Cited by 59 · see citing works
<i>In Vitro</i> Detection System to Evaluate the Immunogenic Potential of Xenografts
Daugs, A., Lehmann, N., Eroglu, D., Meinke, M. C., Markhoff, A., & Bloch, O. (2018) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2017.0532 · Cited by 16 · see citing works
- Authors
- Böer, U., Lohrenz, A., Klingenberg, M., Pich, A., Haverich, A., & Wilhelmi, M.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Böer, Ulrike
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 32
- Issue
- 36
- Pages
- 9730-9737
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2006864740
- Cited by
- 107
- References
- 3
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 5 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 8 · 2018: 5 · 2017: 11 · 2016: 5 · 2015: 8 · 2014: 15 · 2013: 7 · 2012: 5
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- “Innovation Fund of Lower Saxony, Germany: GMP model laboratory tissue engineering”.
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- decellularization, vascular grafts, immunogenicity, DNA content, alpha-gal epitope, MHC class I, smooth muscle actin, glyceraldehyde-3-phosphate dehydrogenase, antibody response, acellular matrix
- MeSH terms
- Actins, alpha-Galactosidase, Animals, Antibodies, Antibody Specificity, Epitopes, Blood Vessel Prosthesis, Carotid Arteries, Cell Extracts, Detergents, Horses, Immunization, Muscle, Smooth, Proteins, Mass Spectrometry, Histocompatibility Antigens Class I, Tissue Engineering, Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating), Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review